Records containing: Neuroblastoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-03-07N8: Dose-Intensive Chemotherapy Plus Biologics in the Treatment of Neuroblastoma
-
CLINICAL_TRIALS study record update · 2013-03-05Phase I Study of an Ethanol-Lock Strategy to Prevent Central Venous Catheter Infections Among Patients With High-Risk Neuroblastoma
-
CLINICAL_TRIALS study record update · 2013-02-07A Phase I Study of Fenretinide (NSC #374551) in Children With High Risk Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-02-05A Phase II Trial of Rebeccamycin Analogue (NSC #655649) in Children With Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-02-05A PHASE II STUDY OF DOCETAXEL (TAXOTERE) (NSC# 628503) IN CHILDREN WITH RECURRENT SOLID TUMORS
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-01-18Phase I Study of Oral Beta-Glucan and Intravenous Anti-GD2 Monoclonal Antibody 3F8 Among Patients With Metastatic Neuroblastoma
-
CLINICAL_TRIALS study record update · 2013-01-18Phase I Trial of A1G4 Anti-Idiotypic Monoclonal Antibody With Bacille-Calmette-Guerin (BCG) Adjuvant in High Risk Patients With GD2 Positive Tumors
-
CLINICAL_TRIALS study record update · 2013-01-17Phase II Study of Anti-GD2 3F8 Antibody and Biologic Response Modifiers for High-risk Neuroblastoma
-
CLINICAL_TRIALS study record update · 2012-11-22Study to Infuse Haploidentical Natural Killer Cells in Patients With Relapsed or Refractory Neuroblastoma
-
CLINICAL_TRIALS study record update · 2012-11-06Tissue Bank for Studies Related to Graft-Versus-Host Disease (GVHD)
-
CLINICAL_TRIALS study record update · 2012-11-06PEPI: Protracted Etoposide in a Phase II Upfront Window for Induction Therapy for High Risk Neuroblastoma
-
CLINICAL_TRIALS study record update · 2012-10-29Phase I Study of Chemokine and Cytokine Gene Modified Autologous Neuroblastoma Cells for Treatment of Relapsed/Refractory Neuroblastoma Using an Adenoviral Vector (CYCHE)
-
CLINICAL_TRIALS study record update · 2012-07-27A Pilot Study of Gene Modified Autologous Neuroblastoma Vaccine for the Post-Chemotherapy Treatment of High-Risk Neuroblastoma
-
CLINICAL_TRIALS study record update · 2012-07-11Exploring the Possibility to Use Glycosyltransferase as a Prognosis Marker of Neuroblastoma
-
CLINICAL_TRIALS study record update · 2012-06-04Evaluation of Benefit and Side Effects of 131I-MIBG in Combination With Myeloablative Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation for the Treatment of High-risk Neuroblastoma
-
CLINICAL_TRIALS study record update · 2012-04-17A Dose Finding Study (Phase I) of the Combination of ZD1839 (Iressa®) and an Oral Formulation of Irinotecan (Camptosar™) in Children With Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-04-02A Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Doses of Cisplatin for Children With Peritoneal Carcinomatosis or Advanced Peritoneal and Retroperitoneal Disease
-
CLINICAL_TRIALS study record update · 2012-03-15Phase I Trial and Pharmacokinetic Study of ABT-751, an Orally Bioavailable Tubulin Binding Agent, on a 7 Day and 21 Day Dosing Schedule in Pediatric Patients With Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-03-15Phase I Trial and Pharmacokinetic Study of BMS-247550 (NSC 710428, Ixabepilone), an Epothilone B Analog, in Pediatric Patients With Refractory Solid Tumors and Leukemias
-
CLINICAL_TRIALS study record update · 2012-03-15A Phase I Trial and Pharmacokinetic Study of Talabostat (PT-100, Val-Boro-Pro) in Combination With Temozolomide or Carboplatin in Pediatric Patients With Relapsed or Refractory Solid Tumors Including Brain Tumors
-
CLINICAL_TRIALS study record update · 2012-03-08A Phase I-II Safety, Tolerability And Pharmacokinetic Study Of Ravuconazole For Prophylaxis Of Invasive Fungal Infections In Patients Undergoing Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2012-03-06Phase I and Pharmacokinetic Study of Enzastaurin (LY317615) in Children and Adolescents With Refractory Primary CNS Tumors
-
CLINICAL_TRIALS study record update · 2012-02-02The Effect of Nurse Case Manager Model on Caregiver's Adaptation of Disease Uncertainty About Their Child With Neuroblastoma
-
CLINICAL_TRIALS study record update · 2011-12-15A Phase I Study of ZD6474 (Zactima) Alone and in Combination With Retinoic Acid in Relapsed and Refractory Pediatric Neuroblastoma
-
CLINICAL_TRIALS study record update · 2011-11-30Donor Lymphocyte Infusion (DLI) as Adoptive Immunotherapy for Relapse Malignancies After Allogeneic Hematopoietic Transplantation